Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Packer

Showing results (71-80 of 326) with videos related to

Pageof 33
Sort By:
Drugs|July 1, 1982
Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classificationM Packer
Circulation|February 1, 1990
Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failureM Packer
Circulation|January 1, 1992
Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failureM Packer
The American Journal of Cardiology|July 1, 1987
Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibitionM Packer
Cardiovascular Drugs and Therapy|February 1, 1993
Calcium antagonists for congestive heart failure: evolving concepts in bridge buildingM Packer
Journal of the Mississippi State Medical Association|October 1, 1972
Radiologic seminar CXXI: hemomediastinum associated with anticoagulant therapyJ M Packer
Biochimica Et Biophysica Acta|December 16, 1985
Coupling factor activity of the purified pea mitochondrial F1-ATPaseA Horak, M Packer
The American Journal of Cardiology|October 1, 1978
Oral vasodilator therapy for chronic heart failure: a plea for cautionM Packer, J Meller
Journal of the American College of Cardiology|March 1, 1991
Management of patients with heart failure and angina: do coexistent diseases alter the response to cardiovascular drugs?M Packer, M L Kukin
Circulation|February 1, 1986
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failureW H Lee, M Packer
Pageof 33

Showing results (71-80 of 326) with videos related to

Sort By:
Pageof 33
Drugs|July 1, 1982
Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classificationM Packer
Circulation|February 1, 1990
Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failureM Packer
Circulation|January 1, 1992
Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failureM Packer
The American Journal of Cardiology|July 1, 1987
Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibitionM Packer
Cardiovascular Drugs and Therapy|February 1, 1993
Calcium antagonists for congestive heart failure: evolving concepts in bridge buildingM Packer
Journal of the Mississippi State Medical Association|October 1, 1972
Radiologic seminar CXXI: hemomediastinum associated with anticoagulant therapyJ M Packer
Biochimica Et Biophysica Acta|December 16, 1985
Coupling factor activity of the purified pea mitochondrial F1-ATPaseA Horak, M Packer
The American Journal of Cardiology|October 1, 1978
Oral vasodilator therapy for chronic heart failure: a plea for cautionM Packer, J Meller
Journal of the American College of Cardiology|March 1, 1991
Management of patients with heart failure and angina: do coexistent diseases alter the response to cardiovascular drugs?M Packer, M L Kukin
Circulation|February 1, 1986
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failureW H Lee, M Packer
Pageof 33